Wuxi Seliwei Biotechnology Co., Ltd.

Product name: Cilostazole

English Name: Cilostazol

CAS: 73963-72-1

Molecular formula: C20H27N5O2

Molecular weight: 369.46

EINECS No. 1312995-182-4

Standard: enterprise standard

Natural/synthetic: synthesis

Level: pharmaceutical grade

Content: 99%

Appearance: white powder

Packaging: 25KG/cardboard barrel detachable

Ingredients: 6-[4-(1-cyclohexyl-5-tetrazole) butoxy]-1,2,3,4-tetrahydro-2-oxoquinoline. According to the calculation of dried products, the content of C20H27N5O2 should be 98.0%-102.0%.

Physical and chemical properties: white or white crystalline powder; odorless. This product is soluble in glacial acetic acid or trichloromethane, dimethylformamide, methanol or absolute ethanol, and almost insoluble in water, 0.1 mol/L hydrochloric acid or 0.1 mol/L sodium hydroxide solution.

Category: Pharmaceutical raw materials

Industry: Medicine

Domain: Antiplatelet aggregators

Extended products: Cilostazole capsules

Application: 1. Cilostazole has the function of vasodilation and anti-platelet. It is used to treat chronic arterial occlusion caused by atherosclerosis, arteritis, occlusive thromboangiitis and diabetes mellitus. 2. Cilostazole can improve chronic ulcer, pain, cold sensation and intermittent claudication caused by limb ischemia, and can be used as supplementary treatment after angioplasty, vascular transplantation and sympathectomy to help relieve symptoms, improve circulation and inhibit thrombosis in transplanted blood vessels.

Usage: It can obviously inhibit platelet aggregation induced by various aggregation inducers, and can dissociate aggregates without causing secondary aggregation. It has obvious anti-thrombotic effect on the model of cerebral circulation and peripheral circulation disorders caused by collagen, ADP, arachidonic acid and sodium laurate. For chronic arterial occlusive ulcer, pain and cold feeling and other local ischemic diseases.

Purpose: Antiplatelet drugs.

Usage: Anticoagulant.

Usage and dosage: 50-100 mg each time, twice a day, young patients can increase dosage appropriately according to symptoms when necessary.